SIROLIMUS DOSE-NORMALIZED TROUGHS WERE AFFECTED BY TIME POST SIROLIMUS INITIATION, CONCOMITANT TACROLIMUS THERAPY, AND MDR-1 3435C > T POLYMORPHISM IN RENAL TRANSPLANT PATIENTS WHO ARE CYP3A5 NON-EXPRESSERS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sam, W-J; Chamberlain, CE; Lee, S-J; Goldstein, JA; Hale, DA; Kirk, AD; Mannon, RB; Hon, YY

Published Date

  • September 1, 2009

Published In

Volume / Issue

  • 49 / 9

Start / End Page

  • 1107 - 1107

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0091-2700

Conference Name

  • 38th Annual Meeting of the American-College-of-Clinical-Pharmacology

Conference Location

  • San Antonio, TX

Conference Start Date

  • September 13, 2009

Conference End Date

  • September 15, 2009